Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.95 USD | +1.77% | +3.82% | -6.80% |
Mar. 04 | Armata Pharmaceuticals Secures $35 Million Credit Agreement From Innoviva Unit | MT |
Mar. 04 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2024 * | 301M | Sales 2025 * | 334M | Capitalization | 945M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.77 x |
Net Debt 2024 * | 187M | Net Debt 2025 * | 106M | EV / Sales 2025 * | 3.15 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 112 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.34% |
Latest transcript on Innoviva, Inc.
1 day | +1.77% | ||
1 week | +3.82% | ||
Current month | -1.90% | ||
1 month | +1.08% | ||
3 months | -10.85% | ||
6 months | +16.43% | ||
Current year | -6.80% |
Managers | Title | Age | Since |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 20-05-19 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 23-08-20 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 14-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-02-11 | |
Director/Board Member | 53 | 22-12-31 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 18-02-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.46% | 29 M€ | -5.60% | ||
0.40% | 27 M€ | -5.75% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 14.95 | +1.77% | 635,949 |
24-04-18 | 14.69 | +1.45% | 636,366 |
24-04-17 | 14.48 | +0.07% | 520,564 |
24-04-16 | 14.47 | +0.49% | 499,195 |
24-04-15 | 14.4 | -1.57% | 552,445 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-6.80% | 929M | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- INVA Stock